IVD in China - Market Research, Industry Trends, Market Share


Published: 04/12/2018
Pages: 138
Full Study Price: US$ 3,995

As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging.

The report is designed to provide the reader with an overview of the Chinese laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

  • Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC), includes urinalysis and blood chemistry testing.
  • Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza)
  • Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
  • Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases, including POC and non-POC blood gas and electrolytes, and glucose self-monitoring tests.
  • Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • Introduction
      • Table Market Drivers and Restraints: IVD Market in China
    • Scope and Methodology
    • Major Findings of the Report
    • IVD Market in China
      • Table China IVD Market, 2017 and 2022 ($ millions)
  • China in Context
    • Overview
      • Table China IVD Market vs. China Medical Device Market, 2017-2022
      • Table China Market Dynamics
    • Population Trends
      • Table Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
      • Table Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
      • Table Total Number of Births in China by Year, 1990-2010 and Forecast 2020-2050
      • Table China Life Expectancy at Birth in Years, 2010-2050
      • Table Elderly Dependency Ratio in China and Other Select Countries, 2010 and 2050
    • Disease Demographics
      • Diabetes
      • Cancer
        • Table Top 5 Cancers Affecting Chinese Population (ranked by total number of cases), 2010-2017
      • Cardiovascular Disease
    • Infectious Disease Threats
      • Hepatitis
      • HIV/AIDS
      • Tuberculosis
    • Chinese Economy
      • Table China GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
  • Clinical Laboratory Structure in China
    • Clinical Laboratory Tests
      • Test Types
        • Table Types of IVD and Clinical Laboratory Tests, 2018
      • VVenues for Test Usage
        • Table Utilization of Beds in Medical Institutions: China's Average Length of Stay is Increasing Slightly, 1985-2016
        • Table Number of Visits and Admissions to Hospital Institutions in China Annually, 2015
      • Urban vs. Rural IVD Market
        • Table China In Vitro Diagnostic Reagent Sales by Urban/Rural Environment, 2017
        • Table Province-level Administrative Divisions of China
        • Table Per Capita IVD Expenditures by China Province/Region, 2017 (Guangdon, Shangdon, Henan Sichuan, Jiangsu, Hebei, Hunan, Anhui, Hubei, Zhejiang, Others)
        • Table China IVD Market by Province/Region
    • Chinese Healthcare Reform and Hospital Infrastructure
    • China Regulation and Medical Device Policy Challenges
      • Distribution in China
      • Medical Device Regulation Overview: China
  • IVD Markets in China
    • Market Introduction and Summary
      • Table China In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening, POC Glucose, POC Other, ID/AST, Microbiology Molecular, PT/INR Lab, Blood Group/Typing, Blood Type Molecular, HPV, CTC, Others)
      • Table China In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
      • Table China In Vitro Diagnostic Sales by Market Segment, 2017 Market Distribution (%)
    • Clinical Chemistry
      • Table China - Clinical Chemistry IVD Market, 2017-2022
      • Table China - Clinical Chemistry IVD Market Distribution, 2017-2022 (%)
      • Table China - Clinical Chemistry IVD Market Value by Segment, 2017 vs. 2022
    • Point-of-Care (POC) Testing
      • Table China - Point-of-Care IVD Market, 2017-2022
      • Table China - Point-of-Care IVD Market Distribution, 2017-2022 (%)
      • Table China - Point-of-Care IVD Market Value by Segment, 2017 vs. 2022
    • Immunoassays
      • Table China - Immunoassay IVD Market, 2017-2022
      • Table China - Immunoassay IVD Market Distribution, 2017-2022 (%)
      • Table China - Immunoassay IVD Market Value by Segment, 2017 vs. 2022
    • Molecular Assays
      • Table China - Molecular Assay IVD Market, 2017-2022
      • Table China - Molecular Assay IVD Market Distribution, 2017-2022 (%)
      • Table China - Molecular Assay IVD Market Value by Segment, 2017 vs. 2022
      • Table HIV Statistics in China, 2016
    • Hematology
      • Table China - Hematology IVD Market, 2017-2022
    • Coagulation
      • Table China - Coagulation IVD Market, 2017-2022
    • Microbiology
      • Table China Infectious Disease Classification Tier, December 2017 Impact
      • Table China - Microbiology IVD Market, 2017-2022
      • Table China - Microbiology IVD Market Distribution, 2017-2022 (%)
      • Table China - Microbiology IVD Market Value by Segment, 2017 vs. 2022
    • Tests Used in Blood Banking
      • Table China - Blood Bank Test IVD Market, 2017-2022
      • Table Prevalence of Transfusion-transmissible Infections in Blood Donations (Median, Interquartile range (IQR), by Income Group
    • Histology and Cytology
      • Table China - Histology/Cytology IVD Market, 2017-2022
      • Table China - Histology/Cytology IVD Market Distribution, 2017-2022 (%)
      • Table China - Histology/Cytology IVD Market Value by Segment, 2017 vs. 2022
    • Prenatal and Genetic Test Services
  • Company Activity in China
    • China IVD Market Participant Overview
    • Abbott Laboratories
    • Arkray
    • Becton, Dickinson & Co.
    • bioMérieux, Inc.
    • Bio-RAD Laboratories, Inc.
    • Danaher Corp.
    • Hologic, Inc.
    • Horiba Medical
    • Instrumentation Laboratory
    • Laboratory Corporation of America
    • Luminex Corporation
    • MedMira
    • Mindray Medical International, Ltd.
    • Myriad Genetics
    • Ortho Clinical Diagnostics
    • PerkinElmer
    • Promega Corporation
    • Qiagen N.V.
    • Roche
    • Shanghai Kehua Bio-engineering
    • Siemens AG
    • Sysmex Corp.
    • Thermo Fisher Scientific
  • Sources of Information